Central Health Care Planning Administration (CHCPA) that will
indirectly benefit the President today. These deals will bring an
increase in income to several of the companies he uses to manage his
assets while he is in office. This arrangement helps our great leader
comply with conflict-of-interest rulings that limit what the President
can and can't engage in while in office. The companies will not
actually be producing or selling the medicines but will contract with
foreign countries so they can continue to produce the medicines used
by CHCPA medical facilities.
In a related story there has been an increase in the number of birth
defects being found in babies being born in America. There are
requests on file in the countries that produce the medicines used in
CHCPA medical facilities to allow the FDA to review the production
methods being used but these requests continue to go unanswered.
